Company Filing History:
1 out of 2 
1 out of 11 
Years Active: 2007
Title: Jae-Young Chang: Innovator in Biopharmaceuticals
Introduction
Jae-Young Chang is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on fusion proteins. His research focuses on developing therapeutic solutions for diseases related to cancer.
Latest Patents
Jae-Young Chang holds a patent for a human serum albumin-TIMP2 fusion protein, which includes a polynucleotide encoding the same and a method for producing this fusion protein. The invention provides a stable human serum albumin-TIMP2 fusion protein that retains the activity of TIMP2. This fusion protein can be utilized in pharmaceutical compositions aimed at treating diseases associated with angiogenesis and metastasis of cancer cells. He has 1 patent to his name.
Career Highlights
Throughout his career, Jae-Young Chang has worked with various companies, including Leadbio, Inc. and Angiolab, Inc. His expertise in biopharmaceuticals has positioned him as a valuable asset in the industry.
Collaborations
Jae-Young Chang has collaborated with several professionals in his field, including Jeong-Yoon Kim and Min-Young Kim. These collaborations have further enhanced his research and development efforts.
Conclusion
Jae-Young Chang's innovative work in the development of biopharmaceuticals demonstrates his commitment to advancing medical science. His contributions, particularly in the area of fusion proteins, hold promise for future therapeutic applications.